Signify Health (SGFY) – Research Analysts’ Weekly Ratings Updates

Signify Health (NYSE: SGFY) recently received a number of ratings updates from brokerages and research firms:

  • 9/7/2022 – Signify Health was downgraded by analysts at UBS Group AG from a “buy” rating to a “neutral” rating. They now have a $30.50 price target on the stock, up previously from $27.00.
  • 9/7/2022 – Signify Health was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating.
  • 9/7/2022 – Signify Health is now covered by analysts at Truist Financial Co.. They set a “hold” rating and a $30.50 price target on the stock.
  • 9/6/2022 – Signify Health had its price target raised by analysts at Royal Bank of Canada from $20.00 to $30.50. They now have a “sector perform” rating on the stock.
  • 9/6/2022 – Signify Health was downgraded by analysts at BTIG Research from a “buy” rating to a “neutral” rating.
  • 9/6/2022 – Signify Health was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $30.50 price target on the stock, down previously from $34.00.
  • 9/6/2022 – Signify Health was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $30.50 price target on the stock, down previously from $32.00.
  • 9/6/2022 – Signify Health was downgraded by analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating. They now have a $30.50 price target on the stock, up previously from $28.00.
  • 9/6/2022 – Signify Health was downgraded by analysts at William Blair from an “outperform” rating to a “market perform” rating.
  • 8/30/2022 – Signify Health is now covered by analysts at BTIG Research. They set a “buy” rating and a $35.00 price target on the stock.
  • 8/17/2022 – Signify Health had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $30.00 to $27.00. They now have a “buy” rating on the stock.
  • 8/17/2022 – Signify Health had its price target lowered by analysts at Guggenheim from $34.00 to $30.00. They now have a “buy” rating on the stock.
  • 8/15/2022 – Signify Health had its price target raised by analysts at Cowen Inc. to $24.00.
  • 8/15/2022 – Signify Health had its price target raised by analysts at Barclays PLC to $21.00.
  • 8/9/2022 – Signify Health had its price target raised by analysts at Barclays PLC to $21.00.
  • 8/8/2022 – Signify Health had its price target raised by analysts at Cowen Inc. from $14.00 to $24.00.
  • 8/8/2022 – Signify Health had its price target raised by analysts at Cowen Inc from $14.00 to $24.00.
  • 7/28/2022 – Signify Health is now covered by analysts at Royal Bank of Canada. They set a “sector perform” rating and a $18.00 price target on the stock.

Signify Health Price Performance

Shares of SGFY opened at $29.23 on Tuesday. Signify Health, Inc. has a 1 year low of $10.70 and a 1 year high of $29.88. The company has a debt-to-equity ratio of 0.31, a current ratio of 5.23 and a quick ratio of 5.23. The company has a market capitalization of $6.85 billion, a price-to-earnings ratio of -15.30 and a beta of 0.71. The business has a 50-day moving average of $22.95 and a 200-day moving average of $17.70.

Signify Health (NYSE:SGFYGet Rating) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.13. Signify Health had a positive return on equity of 5.82% and a negative net margin of 40.14%. The company had revenue of $246.20 million during the quarter, compared to the consensus estimate of $249.57 million. As a group, equities research analysts anticipate that Signify Health, Inc. will post -2.06 earnings per share for the current year.

Institutional Investors Weigh In On Signify Health

Several large investors have recently added to or reduced their stakes in SGFY. Frontier Capital Management Co. LLC grew its stake in Signify Health by 71.4% during the second quarter. Frontier Capital Management Co. LLC now owns 2,956,188 shares of the company’s stock worth $40,795,000 after purchasing an additional 1,231,088 shares during the period. Point72 Asset Management L.P. grew its stake in Signify Health by 88.8% during the second quarter. Point72 Asset Management L.P. now owns 2,437,800 shares of the company’s stock worth $33,642,000 after purchasing an additional 1,146,372 shares during the period. ARK Investment Management LLC grew its stake in Signify Health by 4.9% during the first quarter. ARK Investment Management LLC now owns 20,992,230 shares of the company’s stock worth $381,009,000 after purchasing an additional 981,902 shares during the period. Invesco Ltd. grew its stake in Signify Health by 102.2% during the fourth quarter. Invesco Ltd. now owns 854,468 shares of the company’s stock worth $12,151,000 after purchasing an additional 431,974 shares during the period. Finally, Los Angeles Capital Management LLC acquired a new stake in Signify Health during the second quarter worth approximately $5,605,000. Institutional investors and hedge funds own 90.07% of the company’s stock.

Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.

Featured Stories

Receive News & Ratings for Signify Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Signify Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.